Skip to main content

Immix Biopharma, Inc.

IMMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001873835

No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Immix Biopharma, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IMMX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2523−2
Shares4.09M2.87M−1.22M (−29.9%)
Value$6.10M$6.32M+$212.8K (+3.5%)

New holders (5)

Institutions that held Immix Biopharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IMMX in Q4 2024
InstitutionSharesValue% of portfolio
FNY Investment Advisers, LLC28,750$63.0K0.03%
Jane Street Group, LLC17,523$38.6K0.00%
SBI Securities Co., Ltd.17,500$38.5K0.00%
JPMorgan Chase & Co38$840.00%
Simplex Trading, LLC22$00.00%

Sold out (7)

Institutions that held Immix Biopharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IMMX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
AIGH Capital Management LLC1,123,663$1.67M
Invst, LLC27,000$40.2K
Tritonpoint Wealth, LLC24,526$38.3K
Millennium Management LLC21,521$32.1K
Old National Bancorp10,000$14.9K
Steward Partners Investment Advisory, LLC1,492$2.22K
Advisor Group Holdings, Inc.950$1.42K